Skip to main content

AXA S.A.

SEC CIK
0000898427
Latest filing
Aug 14, 2026

KRTX holding history

Karuna Therapeutics, Inc. in every 13F filed by AXA S.A., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KRTX overviewAll 13F holders of KRTXFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
11
Since Q1 2021
Holdings of KRTX by AXA S.A., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−35,415−100.0%Sold outHolders
Q3 202335,415$5.99M<0.1%−126−0.4%ReducedHolders
Q2 202335,541$7.71M<0.1%+16,913+90.8%AddedHolders
Q1 202318,628$3.38M<0.1%−22,537−54.7%ReducedHolders
Q4 202241,165$8.09M<0.1%−222−0.5%ReducedHolders
Q3 202241,387$9.31M<0.1%−6,344−13.3%ReducedHolders
Q2 202247,731$6.04M<0.1%−929−1.9%ReducedHolders
Q1 202248,660$6.17M<0.1%−25,811−34.7%ReducedHolders
Q4 202174,471$9.76M<0.1%+889+1.2%AddedHolders
Q3 202173,582$9.00M<0.1%+2,709+3.8%AddedHolders
Q2 202170,873$8.08M<0.1%−102−0.1%ReducedHolders
Q1 202170,975$8.53M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.